{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:19:24Z","timestamp":1794035964270,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40266-024-01177-y","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:45:25Z","timestamp":1737459925000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychotropic Polypharmacy in Dementia: A Retrospective Analysis for People with Neuropsychiatric Symptoms Referred to an Australian Dementia Support Service"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-3245","authenticated-orcid":false,"given":"Mustafa","family":"Atee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6461-6846","authenticated-orcid":false,"given":"Andrew","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-7684","authenticated-orcid":false,"given":"Daniel","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-3309","authenticated-orcid":false,"given":"Ya Ping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nyakaboyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Warnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-6095","authenticated-orcid":false,"given":"Thomas","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"1177_CR1","unstructured":"Australian Institute of Health and Welfare. Dementia in Australia. Australian Government; 2023. https:\/\/www.aihw.gov.au\/reports\/dementia\/dementia-in-aus\/contents\/about. Accessed 20 Oct 2023."},{"key":"1177_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2012.00073","volume":"3","author":"J Cerejeira","year":"2012","unstructured":"Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73. https:\/\/doi.org\/10.3389\/fneur.2012.00073.","journal-title":"Front Neurol"},{"issue":"8","key":"1177_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1756285617712979","volume":"10","author":"OP Tible","year":"2017","unstructured":"Tible OP, Riese F, Savaskan E, von Gunten A. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017;10(8):297\u2013309. https:\/\/doi.org\/10.1177\/1756285617712979.","journal-title":"Ther Adv Neurol Disord"},{"key":"1177_CR4","unstructured":"Guideline Adaptation Committee. Clinical practice guidelines and principles of care for people with dementia. NHMRC Cognitive Decline Partnership Centre\u2014Guideline Adaptation Committee; 2016."},{"issue":"10","key":"1177_CR5","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/jcm12103389","volume":"12","author":"WM Bezabhe","year":"2023","unstructured":"Bezabhe WM, Radford J, Salahudeen MS, et al. Ten-year trends in psychotropic prescribing and polypharmacy in Australian general practice patients with and without dementia. J Clin Med. 2023;12(10):3389. https:\/\/doi.org\/10.3390\/jcm12103389.","journal-title":"J Clin Med"},{"issue":"12","key":"1177_CR6","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1111\/imj.15608","volume":"51","author":"H Almutairi","year":"2021","unstructured":"Almutairi H, Stafford A, Etherton-Beer C, Flicker L. Pattern of prescription of psychotropics (antipsychotics, antidepressants and benzodiazepines) in Western Australian residential aged care facilities. Intern Med J. 2021;51(12):2140\u20133. https:\/\/doi.org\/10.1111\/imj.15608.","journal-title":"Intern Med J"},{"key":"1177_CR7","volume-title":"Psychotropic drugs","author":"NL Keltner","year":"2005","unstructured":"Keltner NL, Folks DG. Psychotropic drugs. 4th ed. St. Louis: Elsevier\/Mosby; 2005.","edition":"4"},{"issue":"3","key":"1177_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2850.2012.01911.x","volume":"20","author":"E Galik","year":"2013","unstructured":"Galik E, Resnick B. Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents. J Psych Mental Health Nurs. 2013;20(3):244\u201352. https:\/\/doi.org\/10.1111\/j.1365-2850.2012.01911.x.","journal-title":"J Psych Mental Health Nurs"},{"issue":"5","key":"1177_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2040622316658463","volume":"7","author":"RR Tampi","year":"2016","unstructured":"Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229\u201345. https:\/\/doi.org\/10.1177\/2040622316658463.","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"1177_CR10","doi-asserted-by":"publisher","first-page":"87.e15","DOI":"10.1016\/j.jamda.2016.09.019","volume":"18","author":"L Saarelainen","year":"2017","unstructured":"Saarelainen L, Tolppanen A-M, Koponen M, et al. Risk of hip fracture in benzodiazepine users with and without Alzheimer disease. J Am Med Dir Assoc. 2017;18(1):87.e15-87.e21. https:\/\/doi.org\/10.1016\/j.jamda.2016.09.019.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"1177_CR11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1017\/S1041610220004032","volume":"33","author":"DJ Jester","year":"2021","unstructured":"Jester DJ, Molinari V, Zgibor JC, Volicer L. Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis. Int Psychogeriatr. 2021;33(10):1083\u201398. https:\/\/doi.org\/10.1017\/S1041610220004032.","journal-title":"Int Psychogeriatr"},{"key":"1177_CR12","unstructured":"National Association of State Mental Health Program Directors. Technical report on psychiatric polypharmacy. Alexandria, Virginia. 2001. https:\/\/www.nasmhpd.org\/sites\/default\/files\/Polypharmacy.pdf. Accessed 24 Nov 2024."},{"issue":"3","key":"1177_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/bcp.14527","volume":"87","author":"J Brett","year":"2021","unstructured":"Brett J, Pearson SA, Daniels B, Wylie CE, Buckley NA. A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy. Br J Clin Pharmacol. 2021;87(3):1369\u201377. https:\/\/doi.org\/10.1111\/bcp.14527.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"1177_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jama.2021.1195","volume":"325","author":"DT Maust","year":"2021","unstructured":"Maust DT, Strominger J, Kim HM, et al. Prevalence of central nervous system\u2013active polypharmacy among older adults with dementia in the US. J Am Med Assoc. 2021;325(10):952\u201361. https:\/\/doi.org\/10.1001\/jama.2021.1195.","journal-title":"J Am Med Assoc"},{"key":"1177_CR15","doi-asserted-by":"publisher","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Ger Soc 2023;71(7):2052\u201381. https:\/\/doi.org\/10.1111\/jgs.18372","DOI":"10.1111\/jgs.18372"},{"issue":"5","key":"1177_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","volume":"72","author":"DT Maust","year":"2015","unstructured":"Maust DT, Kim HM, Seyfried LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. J Am Med Assoc Psychol. 2015;72(5):438\u201345. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.3018.","journal-title":"J Am Med Assoc Psychol"},{"issue":"1","key":"1177_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12877-023-04353-8","volume":"23","author":"SC Trenaman","year":"2023","unstructured":"Trenaman SC, Quach J, Bowles SK, Kirkland S, Andrew MK. An investigation of psychoactive polypharmacy and related gender-differences in older adults with dementia: a retrospective cohort study. BMC Geriatr. 2023;23(1):683. https:\/\/doi.org\/10.1186\/s12877-023-04353-8.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1177_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0891988706292762","volume":"20","author":"S Zuidema","year":"2007","unstructured":"Zuidema S, Koopmans R, Verhey F. Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. J Geriatr Psychiatry Neurol. 2007;20(1):41\u20139. https:\/\/doi.org\/10.1177\/0891988706292762.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"2","key":"1177_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/jad-160828","volume":"56","author":"A N\u00f8rgaard","year":"2017","unstructured":"N\u00f8rgaard A, Jensen-Dahm C, Gasse C, Hansen ES, Waldemar G. Psychotropic polypharmacy in patients with dementia: prevalence and predictors. J Alzheimers Dis. 2017;56(2):707\u201316. https:\/\/doi.org\/10.3233\/jad-160828.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1177_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","volume":"28","author":"K Orsel","year":"2018","unstructured":"Orsel K, Taipale H, Tolppanen AM, et al. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer\u2019s disease. Eur Neuropsychopharmacol. 2018;28(11):1260\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.04.005.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1177_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.652254","volume":"12","author":"S Macfarlane","year":"2021","unstructured":"Macfarlane S, Atee M, Morris T, et al. Evaluating the clinical impact of national dementia behaviour support programs on neuropsychiatric outcomes in Australia. Front Psychol. 2021;12: 652254. https:\/\/doi.org\/10.3389\/fpsyt.2021.652254.","journal-title":"Front Psychol"},{"issue":"1","key":"1177_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.12968\/ijpn.2004.10.1.12013","volume":"10","author":"J Abbey","year":"2004","unstructured":"Abbey J, Piller N, Bellis AD, Esterman A, Parker D, Giles L, Lowcay B. The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia. Int J Palliat Nurs. 2004;10(1):6\u201313. https:\/\/doi.org\/10.12968\/ijpn.2004.10.1.12013.","journal-title":"Int J Palliat Nurs."},{"issue":"8","key":"1177_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1159\/000539337","volume":"70","author":"M Atee","year":"2024","unstructured":"Atee M, Morris T, Whiting D, Macfarlane S, Alford M. Insights from a national database for programs supporting neuropsychiatric symptoms of dementia in Australia. Gerontology. 2024;70(8):855\u20137. https:\/\/doi.org\/10.1159\/000539337.","journal-title":"Gerontology"},{"issue":"1","key":"1177_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00019442-200002000-00010","volume":"8","author":"S Wood","year":"2000","unstructured":"Wood S, Cummings JL, Hsu MA, et al. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry. 2000;8(1):75\u201383. https:\/\/doi.org\/10.1097\/00019442-200002000-00010.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"1177_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139. https:\/\/doi.org\/10.1176\/jnp.12.2.233.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1177_CR26","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification. World Health Organization. 2023. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification. Accessed 19 Dec 2023."},{"issue":"9596","key":"1177_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(07)61602-x.","journal-title":"Lancet"},{"key":"1177_CR28","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. UK: Routledge; 1988."},{"issue":"2","key":"1177_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"HY Kim","year":"2017","unstructured":"Kim HY. Statistical notes for clinical researchers: chi-squared test and Fisher\u2019s exact test. Restor Dent Endod. 2017;42(2):152\u20135. https:\/\/doi.org\/10.5395\/rde.2017.42.2.152.","journal-title":"Restor Dent Endod."},{"key":"1177_CR30","unstructured":"R Core Team. The R project for statistical computing. 2023. https:\/\/www.r-project.org\/. Accessed 19 Dec 2023."},{"issue":"3","key":"1177_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/agm2.12175","volume":"4","author":"SX Tan","year":"2021","unstructured":"Tan SX, Cameron SC, Sam LM, et al. A delicate balance: psychotropic polypharmacy and anti-cholinergic use are correlated with fall incidence in Australian inpatients with dementia. Aging Med (Milton). 2021;4(3):193\u2013200. https:\/\/doi.org\/10.1002\/agm2.12175.","journal-title":"Aging Med (Milton)"},{"issue":"67","key":"1177_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"2019","author":"The 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society","year":"2019","unstructured":"The 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society. Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","journal-title":"J Am Geriatr Soc"},{"key":"1177_CR33","unstructured":"International Psychogeriatric Association (IPA). IPA complete guides to behavioral and psychological symptoms of dementia (BPSD). https:\/\/www.ipa-online.org\/publications\/guides-to-bpsd. Accessed 25 Nov 2024."},{"key":"1177_CR34","unstructured":"Pagone G, Briggs L. Final report: care, dignity and respect (royal commission into aged care quality and safety) 2021. Available at https:\/\/www.royalcommission.gov.au\/aged-care\/final-report. Accessed 19 Dec 2023."},{"key":"1177_CR35","unstructured":"Aged Care Quality and Safety Commission, NDIS Quality and Safeguards Commission, Australian Commission on Safety and Quality in Health Care. Joint statement on the inappropriate use of psychotropic medicines to manage the behaviours of people with disability and older people 2022. https:\/\/www.agedcarequality.gov.au\/news-publications\/latest-news\/joint-statement-inappropriate-use-psychotropic-medicines. Accessed 2 Apr 2024."},{"key":"1177_CR36","unstructured":"Australian Commission on Safety and Quality in Health Care. Psychotropic medicines in cognitive disability or impairment clinical care standard. Australian Commission on Safety and Quality in Health Care; 2024. https:\/\/www.safetyandquality.gov.au\/publications-and-resources\/resource-library\/psychotropic-medicines-cognitive-disability-or-impairment-clinical-care-standard. Accessed 2 Apr 2024."},{"key":"1177_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40266-022-00948-9","volume":"39","author":"A Ferro Uriguen","year":"2022","unstructured":"Ferro Uriguen A, Laso Lucas E, Sannino MC, et al. Psychotropic drug prescription in nursing homes during the COVID-19 pandemic. Drugs Aging. 2022;39:467\u201375. https:\/\/doi.org\/10.1007\/s40266-022-00948-9.","journal-title":"Drugs Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01177-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:18:59Z","timestamp":1738750739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01177-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01177-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"22 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. No funding, grant, or financial support was specifically received for the preparation of this manuscript. Dementia Support Australia (DSA) programs are funded by the Australian Government (Department of Health) under the umbrella of the Dementia Aged Care Services (DACS) Fund since 2016. The funder had no role in: the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"M.A. is one of the originators of the PainChek\n                      \u00ae\n                      instrument, which is marketed by PainChek Ltd. (ASX: PCK). He is also a shareholder of PainChek Ltd. He previously held the position of a Senior Research Scientist (October 2018\u2013May 2020) at PainChek Ltd. He had a granted patent titled \u201cA pain assessment method and system; PCT\/AU2015\/000501\u201d in China, Japan, the European Union and the USA, which was assigned to PainChek Ltd. The PainChek\n                      \u00ae\n                      instrument was not mentioned nor cited in this study. Three authors (M.A., D.W., T.M.) are staff members of The Dementia Centre; a research, education, and consultancy arm of HammondCare, an independent Christian charity which auspices the DSA programs. M.A. is a Research and Practice Lead (Team Leader) at The Dementia Centre, HammondCare. D.W. is a Data and Information Analyst at The Dementia Centre, HammondCare. T.M. is Head of Research and Information Excellence at The Dementia Centre, HammondCare. Other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the human research committees of the University of New South Wales (HC190049), University of Sydney (2023\/138), Edith Cowan University (2022-03715) and Curtin University (HRE2023-0069). The study also received institutional approval (R264) from the Research Governance Office of HammondCare. A waiver of informed consent was granted for the study as the data were analysed retrospectively and anonymously. The data were handled by a data custodian who complied with the Declaration of Helsinki of ethical principles, and the National Health and Medical Research Council\u2019s National Statement on Ethical Conduct in Human Research (2018).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"A waiver of informed consent was granted as per the ethics approvals stated above.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All data used in this manuscript will remain confidential to comply with the conditions of service provision of Dementia Support Australia (DSA).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"The authors contributed to the following tasks: conceptualisation: M.A., A.S.; methodology: M.A., A.S., D.W. and T.M.; data curation and data analysis: M.A., A.S.,\u00a0D.W. and T.M.; writing\u2014original draft preparation: M.A., A.S., D.W. and T.M.; writing\u2014review and editing: M.A., A.S., D.W., Y.P.L., C.M., G.N., E.W. and T.M.; resources: M.A., A.S., D.W. and T.M.; supervision: M.A., A.S., Y.P.L. and T.M.; and project administration: M.A., A.S. and T.M. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}